Chemed - CHE Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings or view top-rated stocks.

1 brokers have issued 1 year price objectives for Chemed's shares. Their CHE share price forecasts range from $541.00 to $541.00. On average, they predict the company's stock price to reach $541.00 in the next twelve months. This suggests a possible upside of 19.8% from the stock's current price.
View analysts price targets for CHE or view top-rated stocks among Wall Street analysts.

Chemed's stock was trading at $529.04 at the beginning of the year. Since then, CHE shares have decreased by 14.6% and is now trading at $451.67.
View the best growth stocks for 2022 here.

Chemed saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 263,400 shares, a drop of 7.9% from the August 15th total of 286,000 shares. Based on an average daily trading volume, of 65,000 shares, the short-interest ratio is presently 4.1 days. Approximately 1.8% of the company's stock are short sold.
View Chemed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our CHE earnings forecast.

Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Wednesday, July, 27th. The company reported $4.84 earnings per share for the quarter, topping analysts' consensus estimates of $4.78 by $0.06. The firm earned $531.29 million during the quarter, compared to the consensus estimate of $538.07 million. Chemed had a trailing twelve-month return on equity of 44.64% and a net margin of 12.95%. Chemed's revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the previous year, the business earned $4.60 earnings per share.

Chemed declared a quarterly dividend on Friday, August 5th. Investors of record on Monday, August 15th will be given a dividend of $0.38 per share on Friday, September 2nd. This represents a $1.52 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Friday, August 12th. This is a boost from the stock's previous quarterly dividend of $0.36.
Read our dividend analysis for CHE.

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.34%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

Chemed updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided EPS guidance of $19.30-$19.50 for the period, compared to the consensus EPS estimate of $19.47. The company issued revenue guidance of -.

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CHE stock can currently be purchased for approximately $451.67.

Chemed (NYSE:CHE) has a market capitalization of $6.73 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.98 on an earnings per share basis.

The company employs 14,137 workers across the globe.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.